Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
US9539305B1 · kind B1 · utility
1Cited by
1References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 16, 2015 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Mar 16, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New improved formulations comprising a first composition and a second composition, the first composition being a streptogramin, the second composition being an inhibitor of lipid A deacetylase resulting in permeabilization of an outer membrane of a microorganism to which it is provided to. Said composition, alone or in combination may be used to treat bacterial infections, providing better efficacy, bioavailability and or pharmacokinetics as compared with other antimicrobial agents. The combination may be provided independently or together, and via any route(s) and in any formulation or form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.